Physician profile
Mahesh Krishnan
NPI 1568625408
$114,648.01
in general payments reported to CMS, 2019-2025
5 companies · $71K in 2025
The $71K reported for 2025 was more than what 99% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.84 · 2022: $73.24 · 2023: $41.74 · 2024: $43K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $99K · Travel and Lodging: $15K · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,648.32 |
| Travel and Lodging | $15,269.78 |
| Food and Beverage | $629.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $113,143.39 | 2024-2025 | Hylenex Recombinant |
| Vertex Pharmaceuticals Incorporated | $1,413.17 | 2022-2024 | |
| Csl Behring | $41.74 | 2023 | |
| Akebia Therapeutics INC | $26.84 | 2019 | |
| Antares Pharma, INC. | $22.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahesh Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.